Login / Signup

Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada.

Benedikt FischerWayne JonesMark TyndallPaul Kurdyak
Published in: BMC public health (2020)
Quasi-significant results indicate that recent increases in opioid-related deaths driven by illicit, synthetic opioids tended to be larger in provinces where reductions in prescription opioid availability have been more extensive. It is a plausible explanation that these reductions created supply gaps for non-medical opioid use increasingly filled by illicit, synthetic opioids differentially contributing to opioid-related deaths, generating un-intended adverse effects for previous interventions. General prevention measures to reduce opioid availability, and targeted prevention for at-risk opioid users exposed to toxic drug supply may be include counteractive effects and require coordinated reconciliation.
Keyphrases
  • chronic pain
  • pain management
  • healthcare
  • emergency department
  • cardiovascular events
  • risk factors
  • drug delivery
  • drug induced
  • coronary artery disease